Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Fujisawa identifies novel ACAT inhibitor series, selects development candidate

July 9, 1998

RS-980400: a bone-selective vitamin D analogue with bone anabolic effects

July 9, 1998

Profile of Lilly's LY-333334, a biosynthetic PTH for inducing bone regeneration

July 9, 1998

Noven seeks U.K. approval for second-generation estrogen patch

July 8, 1998

GH secretatogues from Fujisawa

July 8, 1998

Regeneron achieves milestone in Axokine development; receives payment from partner P&G

July 8, 1998

Discovery Labs concludes phase Ib testing of vitamin D3 analogue; success reported

July 8, 1998

Granocyte granted expanded marketing authorization

July 7, 1998

Unigene and Warner-Lambert accelerate development of oral calcitonin product

July 7, 1998

Milestone reached in Millennium/Roche collaboration

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...